Fish Omega 3Here is a great study below on why we should take Omega 3 supplements every day.  The benefits of Omega supplements have been documented to help with a variety of issues.

Instrumental in regulating inflammation, blood pressure and thickness, hormone production, and the activities of the immune and central nervous systems
Important for infants (and a developing fetus) for proper development of the brain and retina of the eyes
Studies suggest that Attention Deficit Hyperactivity Disorder
(ADHD) may be linked to omega-3 deficiency
Deficiencies of omega-3 may also be linked to depression
May be helpful for symptoms of Crohn’s disease
Researchers think omega-3 can help prevent breast, prostate and colon cancers
Supports cardiovascular health by lowering blood pressure, relaxing blood vessels, and lowering cholesterol levels
Has been shown to decrease elevated serum triglycerides
May also reduce pain for sufferers of rheumatoid arthritis
Deficiencies have also been found in people who have allergies, asthma, and skin disorders like eczema and psoriasis

Below is a great information on Omega 3 and Breast Cancer prevention:

Breast cancer is the most common form of cancer in women worldwide. Behaviors appear to affect cancer risk, with about one-third of cases linked to poor diet and lifestyle choices. And growing evidence suggests that early exposure to omega-3 fatty acids from fish (DHA and EPA) may curb breast cancer risks (MacLennan M et al. 2010).

Conversely, diets high in omega-6 fats from vegetable oils appear to raise the risk. Breast cancers differ in dangerousness. Breast cancers fall into two major classes … both dangerous, but one inspires dread. Tumors that feature cells with estrogen receptors are call “ER-positive”. They’re potentially deadly, but often treatable or curable. The one-third of breast tumors that lack estrogen receptors are called “ER-negative”. These aggressive cancers resist treatment and have poor prognoses. About 15 percent of ER-negative cancers are “triple-negative” tumors, whose cells lack receptors for any of the three hormones that fuel ER-positive cancers: estrogen (ER), progesterone (PR), and human epidermal growth factor. Based on very preliminary research, targeted nutrition may help prevent and/or treat triple-negative tumors. Now, a cell study suggests that omega-3 fatty acids from fish may be allies against these tough-to-treat breast tumors.

Toughest tumors may respond to omega-3s. Scientists from Fox Chase Cancer Center set out to see whether fish-source omega-3s would work better or worse against triple-negative breast cancer cells, versus cells from other types of the disease.

Specifically, they wanted to test whether omega-3s from fish (EPA and DHA) and their metabolites would slow or stop the creation of new cells (proliferation) in different kinds of tumors.
(When omega-3s get absorbed into a cancer cell, they’re broken down into smaller molecules called metabolites.) So the Fox team tested the effect of omega-3 EPA and DHA and their metabolites on three ER-positive cell lines and seven triple-negative cell lines. The omega-3s worked against all types of cancer cells. But as the Fox Center said, the impact of omega-3s was “dramatically more pronounced” against triple-negative tumor cells. Encouragingly, fish-derived omega-3s curbed cell-proliferation in triple-negative tumors by up to 90 percent. In addition, omega-3 metabolites cut the triple-negative breast cancer cells’ ability to move by 20 to 60 percent.This study is part of a collaboration between Fox Chase Cancer Center and Pennsylvania State University under a five-year grant awarded by the Komen Foundation. Andrea Manni, M.D., leader of the Pennsylvania State University team, is currently testing the effects of omega-3s and its metabolites on triple-negative breast cancer in rodents. We’ll let you know how those studies turn out.

Information about Life Key Omega 3

Two essential fatty acids (more commonly known as EFAs) essential to human health are omega-3 and omega-6. By far, the best type of omega-3 fat is found in fish. The omega-3 in fish is high in two fatty acids crucial to human health, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). These two fatty acids are pivotal in preventing many diseases. The human brain relies heavily on DHA; low DHA levels have been linked to depression, schizophrenia, memory loss, and a higher risk of developing Alzheimer’s disease.

Researchers are now also linking inadequate intake of these omega-3 fats in pregnant women to premature birth and low birth weight, and to hyperactivity in children. Routine consumption of Mega Potency Fish Oil is highly encouraged and recognized as a key ingredient in improving health.

Our Mega Potency Fish Oil is derived primarily from sardine, mackerel and anchovy, caught in the deep ocean waters off the coast of Peru. Mega Potency Fish Oil delivers 360 mg of EPA and 240 mg of DHA in each softgel.

The specification for the mercury in fish oil is a maximum of 0.005 parts per million or 0.005 mg/kg. There is one gram (which is the equivalent of 1000mg) of fish oil in each softgel; therefore the amount of mercury per softgel is guaranteed to be less than 0.000005 mg. The ppm will always be 0.05 ppm of the fill material.
The molecular distillation processing of our Mega Potency Fish Oil removes any and all dioxins that may be in the oil (tested at less than 1 part per trillion). Dioxin content is measured in a complicated TEQ system and our Mega Potency Fish Oil is guaranteed to meet all USA standards and the stringent European Union (EU) standards. These EU standards are the toughest in the world.

Typical daily dosage is 500 – 3000 mgs; take 1 softgel up to three times daily with a meal.

Click here to purchase Omega 3

Cazzaniga M, Bonanni B. Prevention of ER-negative breast cancer: where do we stand? Eur J Cancer Prev. 2012 Mar;21(2):171-81. doi: 10.1097/CEJ.0b013e32834c9c26. Review. Fox Chase Cancer Center (FCCC). Omega-3 Fatty Acids More Effective at Inhibiting Growth of Triple-Negative Breast Cancer than of Luminal Breast Cancers. April 9, 2013. Accessed at
Gierach GL, Burke A, Anderson WF. Epidemiology of triple negative breast cancers. Breast Dis. 2010;32(1-2):5-24. doi: 10.3233/BD-2010-0319.
Huynh KT, Chong KK, Greenberg ES, Hoon DS. Epigenetics of estrogen receptor-negative primary breast cancer. Expert Rev Mol Diagn. 2012 May;12(4):371-82. doi: 10.1586/erm.12.26. Review
Putti TC, El-Rehim DM, Rakha EA, Paish CE, Lee AH, Pinder SE, Ellis IO. Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis. Mod Pathol. 2005 Jan;18(1):26-35. Secreto G, Zumoff B. Role of androgen excess in the development of estrogen receptor-positive and estrogen receptor-negative breast cancer. Anticancer Res. 2012 Aug;32(8):3223-8. Review.